Kevin O'Leary, a big-name investor known for his no-nonsense approach to business, has a unique strategy for dealing with ...

Bristol Myers' Cobenfy, recently approved by the FDA for schizophrenia, lacks a boxed warning, positioning it as a safer ...

Nvidia Inc. (NASDAQ: NVDA) shares are trading lower Friday, along with the broader semiconductor sector, pulling back after a ...

Analysts' ratings for Graco GGG over the last quarter vary from bullish to bearish, as provided by 4 analysts. The following ...

DirecTV and Dish Network are in advanced talks to merge, potentially creating the largest U.S. pay-TV provider with 20 ...

In 2016, Warren Buffett, the legendary investor and CEO of Berkshire Hathaway, openly criticized Donald Trump during his ...

Just look at Andrew “Boz” Bosworth, Meta's CTO, the guy who invented Facebook's News Feed. Now, he's leading Meta's charge ...

Johnson & Johnson's recent studies reveal impressive response rates for Talvey in combination with Tecvayli and other ...

BlackBerry stock plunges on upbeat Q2 report, beats revenue and EPS estimates with strength in IoT and cybersecurity. RBC ...

Bristol Myers Squibb's Cobenfy has been approved by the FDA as the first new treatment for schizophrenia in decades. The ...

Despite the rate cut, Dimon doesn't believe it'll impact the upcoming U.S. presidential election. His focus remains on the ...

J.B. Hunt shares rose 1.25% to $173.65 after announcing the addition of 20 Nikola Tre fuel cell electric vehicles to enhance ...